Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom
**Objective:** To evaluate the cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole in post-menopausal women with hormone receptor positive (HR+) and human epidermal growth receptor 2 negative (HER2-) advanced breast cancer from a UK payer perspective. **Methods:** A co...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | http://jheor.scholasticahq.com/article/9725-cost-effectiveness-analysis-of-ribociclib-plus-letrozole-versus-palbociclib-plus-letrozole-in-the-united-kingdom.pdf |